Esperion Therapeutics
ESPR
#6138
Rank
A$1.37 B
Marketcap
A$5.80
Share price
-0.77%
Change (1 day)
52.56%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.75. In 2024 the company made an earnings per share (EPS) of A-$0.34 an increase over its 2023 EPS that were of A-$3.17.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79128.52%
2024A-$0.34-89.15%
2023A-$3.17-40.28%
2022A-$5.31-62.87%
2021A-$14.2980.38%
2020A-$7.9250.14%
2019A-$5.28-53.18%
2018A-$11.277.41%
2017A-$10.49110.81%
2016A-$4.9847.35%
2015A-$3.380.89%
2014A-$3.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
A-$8.88 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.07-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.57-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$64.94-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.28-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA